美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

SATELLOS BIOSCIENCE INC.

7.30

+0.27003.84%

盘后：7.300.00000.00%17:10 EDT

成交量：4.74万

成交额：33.80万

市值：1.52亿

市盈率：-4.03

高：7.45

开：6.99

低：6.82

收：7.03

52周最高：13.39

52周最低：5.50

股本：2,083.12万

流通股本：1,751.03万

量比：2.11

换手率：0.27%

股息：- -

股息率：- -

每股收益(TTM):-1.8136

每股收益(LYR):-1.7041

净资产收益率：-50.74%

总资产收益率：-31.38%

市净率：2.15

市盈率(LYR):-4.28

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

SATELLOS BIOSCIENCE INC.

交易所：

NASDAQ

成立时间：

2018

员工人数：

20

公司地址：

Royal Bank Plaza,Suite 2800,South Tower,200 Bay Street,Toronto,Ontario,Canada

官网：

http://www.satellos.com;ir.satellos.com

邮编：

M5J 2J1

电话：

- -

传真：

- -

简介：

Satellos Bioscience Inc.于2006年4月20日根据《商业公司法》（不列颠哥伦比亚省）注册成立。该公司是一家临床阶段的药物开发公司，致力于开发退行性肌肉疾病的治疗方法。其主要候选药物SAT-3247是一种口服小分子，旨在恢复杜氏肌营养不良症等情况下的骨骼肌再生。该候选药物目前正在两项名为BASECAMP和TRAILHEAD的试验中进行临床评估。该公司继续利用其专有的MyoReGenX平台来确定退行性肌肉疾病的额外治疗机会。

董事

名称

职位

Frank Gleeson

Chief Executive Officer and Director and President

Geoff MacKay

Chairman and Director

Adam Mostafa

Director

Brian Bloom

Director

Franklin Berger

Director

Iris Loew Friedrich

Director

Mark Nawacki

Director

Selwyn Ho

Director

Stephanie Brown

Director

股东

名称

职位

Frank Gleeson

Chief Executive Officer and Director and President

Elizabeth Williams

Chief Financial Officer

Michael Rudnicki

Chief Discovery Officer

Phil Lambert

Chief Scientific Officer

Wildon Farwell

Chief Medical Officer

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/MSLE/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MSLE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MSLE\",,,,,undefined,":{"symbol":"MSLE","market":"US","secType":"STK","nameCN":"SATELLOS BIOSCIENCE INC.","latestPrice":7.3,"timestamp":1780084800000,"preClose":7.03,"halted":0,"volume":47432,"hourTrading":{"tag":"盘后","latestPrice":7.3,"preClose":7.3,"latestTime":"17:10 EDT","volume":703,"amount":5146.9451,"timestamp":1780089022410,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.03840682788051203,"floatShares":17510300,"shares":20831190,"eps":-1.813562,"marketStatus":"休市中","change":0.27,"latestTime":"05-29 16:00:00 EDT","open":6.99,"high":7.4499,"low":6.82,"amount":337983.973096,"amplitude":0.089602,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.813562,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1780300800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":7.03,"postHourTrading":{"tag":"盘后","latestPrice":7.3,"preClose":7.3,"latestTime":"17:10 EDT","volume":703,"amount":5146.9451,"timestamp":1780089022410,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.1105840523107635},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MSLE\",,,,,undefined,":{"symbol":"MSLE","floatShares":17510300,"roa":"-31.38%","roe":"-50.74%","lyrEps":-1.704123,"volumeRatio":2.1105840523107635,"shares":20831190,"dividePrice":0,"high":7.4499,"amplitude":0.089602,"preClose":7.03,"low":6.82,"week52Low":5.5,"pbRate":"2.15","week52High":13.3949,"institutionHeld":0,"latestPrice":7.3,"eps":-1.813562,"divideRate":0,"volume":47432,"delay":0,"ttmEps":-1.813562,"open":6.99,"prevYearClose":12.5,"prevWeekClose":6.75,"prevMonthClose":7.95,"prevQuarterClose":5.63,"fiveDayClose":7.14,"twentyDayClose":7.95,"sixtyDayClose":12.27},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MSLE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-15","symbol":"MSLE","fiscalQuarterEnding":"2026/03","expectedEps":-0.51,"name":null,"time":"盘前","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-0.53},{"market":"US","date":"2026-03-27","symbol":"MSLE","fiscalQuarterEnding":"2025/12","expectedEps":-0.36,"name":null,"time":"盘前","type":"earning","dateTimestamp":1774584000000,"reportTimeType":"pre","actualEps":-0.47},{"market":"US","date":"2026-02-06","symbol":"MSLE","reason":null,"defaultRemindTime":1770388200000,"announcedDate":"2026-02-05","type":"delisting","dateTimestamp":1770354000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MSLE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MSLE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1779336000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MSLE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MSLE","date":"2026-05-29","current":-4.025228,"percent":0.868421,"low":-12.479818,"twenty":-10.770158,"median":-6.614029,"eighty":-5.255741,"high":-4.777882,"avg":-7.549182,"sd":2.409533,"marketCap":145462670.32},"quantilePoints":[{"date":"2026-02-13","current":-10.770362,"twenty":-10.948162,"median":-10.770362,"eighty":-10.650272,"marketCap":232264709.51},{"date":"2026-02-20","current":-10.655876,"twenty":-10.961105,"median":-10.795625,"eighty":-10.660269,"marketCap":229795787.77},{"date":"2026-02-27","current":-11.410036,"twenty":-11.040635,"median":-10.847134,"eighty":-10.698718,"marketCap":246059372.56},{"date":"2026-03-06","current":-11.830077,"twenty":-11.717077,"median":-10.918938,"eighty":-10.750564,"marketCap":255117626.85},{"date":"2026-03-13","current":-8.109914,"twenty":-11.50908,"median":-10.908981,"eighty":-10.660269,"marketCap":174891683.43},{"date":"2026-03-20","current":-7.707011,"twenty":-11.414276,"median":-10.795625,"eighty":-8.641353,"marketCap":166203013.02},{"date":"2026-03-27","current":-6.631132,"twenty":-11.347113,"median":-10.74587,"eighty":-7.112164,"marketCap":143001488.38},{"date":"2026-04-02","current":-5.025579,"twenty":-11.228066,"median":-10.659537,"eighty":-6.857362,"marketCap":125001211.63},{"date":"2026-04-10","current":-5.215911,"twenty":-11.093473,"median":-9.47912,"eighty":-5.796539,"marketCap":129735363.26},{"date":"2026-04-17","current":-7.29856,"twenty":-11.048776,"median":-7.908462,"eighty":-5.702641,"marketCap":181537079.31},{"date":"2026-04-24","current":-5.815307,"twenty":-10.982188,"median":-7.307008,"eighty":-5.899657,"marketCap":144644124.23},{"date":"2026-05-01","current":-6.614029,"twenty":-10.910972,"median":-7.101939,"eighty":-6.007657,"marketCap":164510727.14},{"date":"2026-05-08","current":-6.017774,"twenty":-10.898871,"median":-6.946772,"eighty":-6.020777,"marketCap":149680075.96},{"date":"2026-05-15","current":-6.08008,"twenty":-10.857436,"median":-6.796189,"eighty":-6.025643,"marketCap":151229840.1},{"date":"2026-05-22","current":-5.211571,"twenty":-10.78552,"median":-6.687256,"eighty":-5.618291,"marketCap":148529791.46},{"date":"2026-05-29","current":-5.103954,"twenty":-10.770158,"median":-6.614029,"eighty":-5.255741,"marketCap":145462670.32}],"updateTime":1780159886867},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":650365067,"yearFounded":2018,"employeeNum":20,"address":"Royal Bank Plaza,Suite 2800,South Tower,200 Bay Street,Toronto,Ontario,Canada","zipCode":"M5J 2J1","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.satellos.com;ir.satellos.com","stockEarnings":[{"period":"1week","weight":0.0815},{"period":"1month","weight":0.0041},{"period":"3month","weight":-0.4089},{"period":"6month","weight":-0.416},{"period":"ytd","weight":-0.416}],"compareEarnings":[{"period":"1week","weight":0.0145},{"period":"1month","weight":0.0631},{"period":"3month","weight":0.1028},{"period":"6month","weight":0.107},{"period":"1year","weight":0.2821},{"period":"ytd","weight":0.1093}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Satellos Bioscience Inc.于2006年4月20日根据《商业公司法》（不列颠哥伦比亚省）注册成立。该公司是一家临床阶段的药物开发公司，致力于开发退行性肌肉疾病的治疗方法。其主要候选药物SAT-3247是一种口服小分子，旨在恢复杜氏肌营养不良症等情况下的骨骼肌再生。该候选药物目前正在两项名为BASECAMP和TRAILHEAD的试验中进行临床评估。该公司继续利用其专有的MyoReGenX平台来确定退行性肌肉疾病的额外治疗机会。","exchange":"NASDAQ","name":"SATELLOS BIOSCIENCE INC.","nameEN":"SATELLOS BIOSCIENCE INC."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MSLE\",market:\"US\",,,undefined,":{"directors":[{"name":"Frank Gleeson","position":"Chief Executive Officer and Director and President"},{"name":"Geoff MacKay","position":"Chairman and Director"},{"name":"Adam Mostafa","position":"Director"},{"name":"Brian Bloom","position":"Director"},{"name":"Franklin Berger","position":"Director"},{"name":"Iris Loew Friedrich","position":"Director"},{"name":"Mark Nawacki","position":"Director"},{"name":"Selwyn Ho","position":"Director"},{"name":"Stephanie Brown","position":"Director"}],"executives":[{"name":"Frank Gleeson","position":"Chief Executive Officer and Director and President"},{"name":"Elizabeth Williams","position":"Chief Financial Officer"},{"name":"Michael Rudnicki","position":"Chief Discovery Officer"},{"name":"Phil Lambert","position":"Chief Scientific Officer"},{"name":"Wildon Farwell","position":"Chief Medical Officer"}]}}}